High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

Stock Information for High Tide Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About High Tide Inc.

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM
High Tide Secures Credit Approval for C$40MM of Senior Secured Credit Facilities
High Tide to Acquire Northern Helm, Adding Four Established Retail Cannabis Stores in Ontario
High Tide to Open Two New Canna Cabana Locations in Welland and Calgary
High Tide to Announce Second Fiscal Quarter 2026 Financial Results
High Tide to Open New Canna Cabana in Toronto, Ontario
High Tide Announces Purchases of Shares by Insiders
High Tide Reports Record Quarterly Distribution of 7.6 Tonnes of Medical Cannabis Through Remexian Pharma GmbH, Accelerating German Market Leadership

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.